CX-5461: From Pol I Stress to Translational Strategy

2026-09-16

CX-5461 is an RNA polymerase I inhibitor that converts dysregulated ribosome biogenesis into a measurable therapeutic vulnerability. This thought-leadership guide connects Pol I blockade with p53 signaling, DNA damage, mitotic catastrophe, autophagy, senescence, and cisplatin sensitization while outlining practical strategies for translational cancer research.

TPPU: Soluble Epoxide Hydrolase Workflows

2026-09-16

TPPU is a nanomolar soluble epoxide hydrolase inhibitor for connecting fatty acid epoxide signaling with inflammatory pain, redox biology, and osteoclast assays. This practical guide shows how to prepare, benchmark, and troubleshoot TPPU workflows while separating established evidence from emerging liver–bone applications.

ZAK Activation at the Collided Ribosome

2026-09-15

Huso and colleagues define how ribosome collisions activate the MAP3K ZAK through RACK1-dependent assembly and dimerization of ZAK SAM domains at the collision interface. By combining cryo-electron microscopy with biochemical and mutational analyses, the study distinguishes constitutive ribosome recruitment from collision-triggered activation and identifies SERBP1 as a negative regulator.

Carbapenemase Gene Dynamics in CREC Across Guangdong

2026-09-15

Nilotinib (AMN-107) in Kinase Signaling Workflows

2026-09-14

Nilotinib (AMN-107) gives researchers a selective, experimentally tractable way to perturb BCR-ABL, mutant KIT, and PDGFR signaling in cancer models. Its value extends beyond endpoint viability assays: paired with time-resolved phosphoproteomics and ribotoxic-stress analysis, it helps separate kinase-dependent phenotypes from broader stress responses.

Imatinib in Gastric Cancer Assembloid Research

2026-09-14

Imatinib (STI571) can reveal how tumor–stroma interactions reshape kinase-dependent drug responses. This article translates patient-derived gastric cancer assembloid findings into a rigorous framework for mechanism-aware signal transduction research.

Galectin-1, FIP200, and Hepatic Steatosis

2026-09-13

The 2026 reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism linking metabolic stress to autophagy blockade, hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of animal phenotyping, proteomics, interaction mapping, binding analysis, and interface-disrupting mutations provides a mechanistic framework for studying autophagy control in NAFLD.

Cyclosporin A Workflows for Mechanistic Research

2026-09-12

Cyclosporin A supports distinct workflows for calcineurin–NF-AT signaling, mitochondrial permeability transition, and mechanistic immunosuppression. This guide shows how to use it as a pathway probe, how to separate cyclophilin-dependent effects from general toxicity, and how to apply it cautiously alongside the NMDA–Cav2.1 findings in cortical interneuron research.

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine Workflow

2026-09-11

Use PP 3 as a matched negative control to separate Src-dependent effects from vehicle, scaffold, and pathway artifacts in kinase and vascular assays. Its greatest value appears in workflows connecting Src kinase signaling pathway research with NADPH oxidase-derived ROS and L-type calcium-channel responses.

Coronavirus Macrodomains and PARP-Mediated Antiviral Defense

2026-09-11

Grunewald and colleagues showed that coronavirus macrodomains counter a host PARP-dependent restriction pathway: inhibiting or depleting selected PARPs restored replication of macrodomain-mutant virus and reduced interferon production. The study provides a mechanistic framework for interpreting ADP-ribosylation in antiviral immunity and for designing experiments that combine pharmacological inhibition with genetic validation.

Benzyl-activated Streptavidin Magnetic Beads: K1301

2026-09-10

K1301 provides magnetically recoverable streptavidin capture for biotinylated proteins, peptides, antibodies, nucleic acids, and other targets in purification and pull-down workflows. It should not be treated as a universal ligand for non-biotinylated analytes, and the BSA- and sodium azide-containing formulation requires compatibility testing before sensitive enzymatic or live-cell applications; no directly matched paper evidence was supplied.

Phalloidin B7678: F-Actin Workflow Guide

2026-09-10

Phalloidin B7678 is a cyclic heptapeptide toxin for high-affinity F-actin binding, filament stabilization, and endpoint cytoskeleton visualization in fixed or permeabilized samples. It should not be used as a live-cell imaging reagent, a reversible actin probe, or a direct assay for monomeric G-actin.

Benzyl-activated Streptavidin Magnetic Beads

2026-09-09

Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide a magnetically separable surface for capturing biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. They are suitable for validated purification, immunoprecipitation, interaction, screening, and enrichment workflows, but the supplied sodium azide formulation requires washing and validation before any live-cell application.

URB597: From FAAH Target to Pain Biology

2026-09-09

URB597 (KDS-4103) is a selective FAAH inhibitor for dissecting anandamide biology. This article explains how to use its pharmacology to interpret pain, affective, neuroplasticity, and neuroinflammation findings without confusing FAAH-specific effects with broader cannabinoid activity.

Amphotericin B: Mechanism and Research Use

2026-09-08

Amphotericin B is an amphipathic polyene antifungal antibiotic that targets fungal membrane sterols and disrupts ion homeostasis. This evidence-focused guide connects its membrane mechanism, inflammatory signaling, experimental handling, and limits in fungal infection research.